Soluble Interleukin-2 Receptor Levels in Patients with Dermatitis Herpetiformis
- 1 September 1991
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 97 (3) , 568-572
- https://doi.org/10.1111/1523-1747.ep12481904
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseasesClinical Immunology and Immunopathology, 1989
- Elevated soluble interleukin‐2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritisArthritis & Rheumatism, 1988
- Soluble interleukin‐2 receptors in systemic lupus erythematosusArthritis & Rheumatism, 1988
- LymphokinesNew England Journal of Medicine, 1987
- The pathogenesis of dermatitis herpetiformis: Recent advancesJournal of the American Academy of Dermatology, 1987
- HLA-B8DR3 phenotype and the primary immune responseClinical Immunology and Immunopathology, 1985
- SUPPRESSOR-CELL ACTIVITY IN COELIAC DISEASE INDUCED BY ALPHA-GLIADIN, A DIETARY ANTIGENThe Lancet, 1984
- Special characteristics of cellular immune function in normal individuals of the HLA-DR3 typeClinical Immunology and Immunopathology, 1982
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Defective Fc-Receptor Functions Associated with the HLA-B8/DRw3 HaplotypeNew England Journal of Medicine, 1981